SCHEMBL3790835

SCHEMBL3790835

COc1ccc(C(=O)N(C)c2[c]cccc2)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
TSHR P16473 1/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA4 P22748 1/20 0.46
CA6 P23280 1/20 0.46
CA7 P43166 1/20 0.46
TPMT P51580 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
ELANE P08246 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
BCHE P06276 1/20 0.45
ACHE P22303 1/20 0.45
MAPT P10636 3/20 0.45
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17321082 0.79 L3MBTL1 (0.64) CYP2C9CYP2C19CYP1A2CYP3A4TSHR
SCHEMBL482524 0.78 KMT2A (0.45) LMNAMEN1KMT2APOLBALDH1A1
SCHEMBL6409033 0.74 CYP2C9 (0.66) CYP2C9CYP2C19CYP1A2CYP3A4TSHR
SCHEMBL30486023 0.73 TSHR (0.63) CYP2C9CYP2C19CYP1A2CYP3A4TSHR
SCHEMBL1436095 0.73 TSHR (0.63) CYP2C9CYP2C19CYP1A2CYP3A4TSHR
SCHEMBL17035531 0.72 CYP2C9 (0.58) CYP2C9CYP2C19CYP1A2CYP3A4TSHR
SCHEMBL5015216 0.72 KDM4E (0.41) CYP1A2TSHRL3MBTL1MAPTLMNA
SCHEMBL2535686 0.71 TSHR (0.42) TSHRL3MBTL1BCHEACHEMAPT
SCHEMBL1416233 0.71 ALOX5 (0.34) CYP2C19CYP3A4TSHRL3MBTL1MAPT
SCHEMBL14388233 0.70 CYP2C9 (0.63) CYP2C9CYP2C19CYP1A2CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010086366-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2010-08-05 WO disclosed